Guilford (GLFD) - Steadily Rising Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Guilford (GLFD) - Steadily Rising

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: SteveG who wrote (75)	8/25/1997 3:32:00 AM
From: Marty	of 496

Congrats to all who had the foresight to buy Guilford. I happened to buy another biotech R&D co, Neotherapeutics, who is working on the same problem. A lot of the reason I bought was because of the following report. prelude.mcmaster.ca Since the date of this study, NEOT has started human phase 1 testing in the U.S. and I understand that the initial Canadian trials are about concluded. (Successfully) It appears to be the same class of drugs for the same problems. The small molecule solution is the same but beyond that, there may be a difference in approach. I am a layman in biotech. This is just a FYI. This is a huge market and what appears to be a medical breakthrough for both companies. Very good for the industry.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next